Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Emerging Biopharma
Biotech
Drug discovery biotech Vyant preps to wind down operations
Vyant Bio is winding down operations, including reducing its workforce, pursuing strategic alternatives and saying goodbye to CEO John Roberts.
Annalee Armstrong
Feb 3, 2023 10:14am
Days after halting leukemia drug, Magenta to close its doors
Feb 2, 2023 5:06pm
Purple snags Immunorizon's tri-specific antibodies in small M&A
Feb 2, 2023 10:20am
Layoffs still battering biotech, with Big Pharmas piling on pain
Feb 1, 2023 10:50am
More layoffs at Instil as cell therapy production shifts to UK
Feb 1, 2023 10:15am
Despite blockbuster Altos funds, longevity investment falls $1B
Jan 31, 2023 11:28am
More News
UniQure snags rare ALS therapy from Apic Bio for $10M upfront
Jan 31, 2023 10:45am
Structure finalizes $111M IPO; Intensity plots offering
Jan 30, 2023 10:59am
Fierce Biotech Fundraising Tracker: Ribon, Grey Wolf and more
Jan 30, 2023 9:36am
10 top M&A targets in biotech for 2023
Jan 30, 2023 3:00am
See more